PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
2016 · Journal of Hematology & Oncology · 281 citations
https://doi.org/10.1186/s13045-016-0341-7
X
Xi-Wen Bi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
792
Citations
14
h-index
20
i10-index
Xi-Wen Bi is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Viral-associated cancers and disorders & Immune Cell Function and Interaction. The author has an h-index of 14, co-authored 23 publications.
Papers by this author
worksRacial patterns of patients with primary mediastinal large B-cell lymphoma
2016 · Medicine · 42 citations
https://doi.org/10.1097/md.0000000000004054
Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma
2016 · Scientific Reports · 9 citations
https://doi.org/10.1038/srep23996
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: The Phase III MECCA Trial
2025 · Journal of Clinical Oncology · 9 citations
https://doi.org/10.1200/jco.24.00938
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat